| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2007;116:e55-e59.)
© 2007 American Heart Association, Inc.
AHA Conference Proceedings |
Key Words: AHA Conference Proceedings myocardial infarction point-of-care systems angioplasty reperfusion
| Introduction |
|---|
|
|
|---|
In this article, we view these strategies from the perspective of the PCI-capable hospital that "receives" STEMI patients (STEMI-receiving hospital). A primary PCI center is defined as any hospital that performs primary PCI. Patients can present to PCI-capable hospitals through 1 of 3 pathways. Each of these modes of presentation offers opportunities for improving time to treatment and access to primary PCI. The Figure depicts the position of the primary PCI-capable hospital within the system.
|
The Current System
Patient Presentation to a PCI-Capable Hospital
Door-to-balloon time is a focus for improvement at many hospitals because it is a Centers for Medicare and Medicaid Services quality indicator for STEMI. An efficient emergency department (ED) triage system quickly acquires a 12-lead ECG to diagnose STEMI in patients with suggestive symptoms and rapidly activates the cardiac catheterization laboratory. Door-to-balloon times have been shown to be shorter when the emergency physician is able to activate the cardiac catheterization laboratory without consulting a cardiologist.2
Patient Presentation Directly to a PCI-Capable Hospital by EMS
The use of EMS by patients provides the opportunity for prehospital ECG diagnosis of STEMI, as well as notification and activation of the cardiac catheterization laboratory to substantially accelerate door-to-balloon time.3 Prehospital ECGs can be read by computer algorithms, interpreted by trained paramedics, and/or electronically transmitted to the receiving hospital. Unfortunately, >50% of patients with STEMI arrive at the hospital without using EMS, and prehospital ECGs continue to be underutilized. Diagnosis of STEMI in the prehospital phase potentially allows the use of destination protocols to bypass non–PCI-capable hospitals and directly transport patients to the nearest PCI-capable hospital, as shown by the dotted line in the Figure.
Hospital Transfer to a PCI-Capable Hospital
Several recent randomized trials support the safety and efficacy of transferring STEMI patients for primary PCI from community hospitals that do not have PCI capability.4–7 A recent meta-analysis of these trials demonstrated a significant reduction in the composite end point of death, reinfarction, and stroke (Table), although there was only a trend for reduction in death.8 Most of the benefit was in reducing the risk of reinfarction, but this benefit may have been overestimated compared with what would be achieved in most practice settings in the United States, because there was very low use of rescue PCI in the patients initially treated with fibrinolytics (1.9% in the DANish multicenter randomized study of fibrinolytic therapy versus acute coronary angioplasty in Acute Myocardial Infarction [DANAMI]-2).6 Moreover, patients deemed to be high risk for transfer were excluded, and first door-to-balloon times were faster than in most reports from the United States. In the only randomized trial to compare transfer for PCI to fibrinolytics performed in the United States (a small trial that did not meet its enrollment objectives), the median first door-to-balloon time was 155 minutes despite a mean transfer distance of only 32 miles.7
|
In the National Registry of Myocardial Infarction (NRMI 3-4), only 4.2% of US patients transferred from a non–PCI-capable hospital to a PCI-capable hospital had a door-to-balloon time of within 90 minutes as recommended by the American College of Cardiology (ACC)/American Heart Association (AHA) STEMI guideline.9 Thus, although the available data support transfer for primary PCI when transfer times and first door-to-balloon times are rapid, questions remain as to the relevance of these data in typical US practice.
Selected Current Model Systems of STEMI Care in the United States
"Hub and Spoke" Systems of Transfer to Primary PCI Centers
The Minneapolis Heart Institutes level 1 myocardial infarction program has the largest reported experiences designed to integrate the care at non–PCI-capable hospitals (STEMI referral hospitals) with a regional PCI-capable hospital (STEMI-receiving hospital). The program includes rural and community hospitals up to 210 miles away from the STEMI-receiving hospital.10 Key components of the program include (1) empowering the emergency physician (or EMS personnel in certain situations) at the non–PCI-capable hospital to activate the system with a single phone call; (2) the use of a standardized protocol that is simple and systematic; (3) a customized transfer plan for each non–PCI-capable hospital; (4) an in-depth training program for each non–PCI-capable hospital, including EMS, ED, and primary care providers, as well as the local community; (5) a comprehensive quality improvement program; and (6) systems to support the patient and family during the initial hospital stay and on their return to the local community. More than 1345 patients have now been treated with this system, including 297 patients in the STEMI-receiving hospital, 627 patients in 14 hospitals up to 60 miles away (zone 1), and 421 patients in 16 hospitals 60 to 210 miles away (zone 2) from the STEMI-receiving hospital. With this standardized protocol, the median door-to-balloon times from the community STEMI referral hospitals to balloon inflation in the STEMI-receiving hospital were 96 minutes in zone 1 and 118 minutes in zone 2. All patients were included in the protocol and database, which led to a high-risk cohort with 15% of patients >0 years of age, 12% with cardiogenic shock, and 11% with cardiac arrest before arrival in the cardiac catheterization laboratory. Despite this high-risk unselected cohort, the in-hospital, 30-day, and 1-year mortality rates were 4.2%, 4.9%, and 7.2%, respectively, with no differences between patients presenting for primary PCI at the PCI center, zone 1 hospitals, and zone 2 hospitals.11
A statewide approach is being used in North Carolina in the Reperfusion of Acute Myocardial Infarction in North Carolina Emergency Departments (RACE) project, which shares many features of the Minnesota model. The project incorporates standardized protocols and integrated systems for the treatment and timely transfer (when appropriate) of patients with STEMI in 5 geographic regions in North Carolina, which include 70 hospitals, 10 of which are STEMI-receiving hospitals. Although regional centers play a key role in the systems, the goal is not to transfer all patients for primary PCI but rather to also administer fibrinolytic therapy when appropriate according to the ACC/AHA STEMI guideline.2 This project has been created with an alliance between national and regional professional societies, a local payer (Blue Cross and Blue Shield), industry, and healthcare providers, including EMS, emergency medicine, cardiology, and hospital administrations. The program includes
70 hospitals (including 10 STEMI-receiving hospitals). For each hospital, data are collected before and after customized interventions to increase the proportion of eligible patients receiving reperfusion therapy and reduce door-to-balloon and door-to-needle times. The plan includes assessment of the impact of various features on both process and outcomes to allow refinement of strategies for improving application of reperfusion therapy.
Destination Protocols for EMS to Triage to PCI Centers
An urban program has been implemented in Boston, Mass, that involves destination protocols to take STEMI patients directly to qualified PCI-capable hospitals. The Boston EMS has established a "point-of-entry" plan that directly transports STEMI patients to the nearest hospital with primary PCI capabilities.11 To foster collaboration and better care in the region, the project includes an oversight committee composed of representation from the 9 participating hospitals and a data safety and independent monitoring board that includes 5 Boston cardiologists, 1 outside interventional cardiologist, and 1 statistician. The Boston standards for the PCI-capable hospitals include hospital volumes of at least 36 primary PCI procedures per year, performance of immediate angiography in at least 90% of patients transported, and door-to-balloon times of within 120 minutes (more recently within 90 minutes) in at least 75% of ideal patients (eg, patients who are ideal candidates for primary PCI).
The Ideal System for the STEMI-Receiving Hospital
The current ACC/AHA guideline provides the best available recommendations to guide practice for treatment with primary PCI.2 The 2004 update of the STEMI guidelines placed a strong emphasis on systems development and integration of aspects of care for which coordination is needed. Ideal systems can enable STEMI-receiving hospitals to expand optimal reperfusion therapy to millions of Americans. Criteria for such an ideal center are proposed below.
Criteria for Primary PCI Centers
The following are criteria for ideal PCI centers,12 with or without on-site cardiac surgery.
Institutional Resources
Physician Resources
Program Requirements
Other Features of an Ideal System
Current Gaps and Barriers
Barriers to Timely Access to Primary PCI
Recommendations for Research, Programs, and Public Policy
Research
Programs
Public Policy
| Acknowledgments |
|---|
Potential conflicts of interest for members of the writing groups for all sections of these conference proceedings are provided in a disclosure table included with the Executive Summary.
| Footnotes |
|---|
The opinions expressed in this manuscript are those of the authors and should not be construed as necessarily representing an official position of the US Department of Health and Human Services, the Centers for Disease Control and Prevention, the Agency for Healthcare Research and Quality, or the US government. These opinions are not necessarily those of the editor or the American Heart Association.
The Executive Summary for these proceedings is available in the July 10, 2007, issue of Circulation (Circulation. 2007;116:217–230). Writing group reports are available online at http://circ.ahajournals.org (Circulation. 2007;116:e29–e32, e33–e38, e39–e42, e43–e48, e49–e54, e55–e59, e60–e63, e64–e67, e68–e72, and e73–e76).
The publication of these proceedings was approved by the American Heart Association Science Advisory and Coordinating Committee on April 18, 2007. A single reprint of the entire conference proceedings is available by calling 800-242-8721 (US only) or writing the American Heart Association, Public Information, 7272 Greenville Ave, Dallas, TX 75231-4596. Ask for reprint No. 71-0413. To purchase additional reprints, call 843-216-2533 or e-mail kelle.ramsay@wolterskluwer.com.
Expert peer review of AHA Scientific Statements is conducted at the AHA National Center. For more on AHA statements and guidelines development, visit http://www.americanheart.org/presenter.jhtml?identifier=3023366.
Permissions: Multiple copies, modification, alteration, enhancement, and/or distribution of this document are not permitted without the express permission of the American Heart Association. Instructions for obtaining permission are located at http://www.americanheart.org/presenter.jhtml?identifier=4431. A link to the "Permission Request Form" appears on the right side of the page.
| References |
|---|
|
|
|---|
2. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC Jr, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK; American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction) [published correction appears in Circulation. 2005;111:2013]. Circulation. 2004; 110: 588–636.
3. Garvey JL, MacLeod BA, Sopko G, Hand MM; National Heart Attack Alert Program (NHAAP) Coordinating Committee; National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health. Pre-hospital 12-lead electrocardiography programs: a call for implementation by emergency medical services systems providing advanced life support: National Heart Attack Alert Program (NHAAP) Coordinating Committee; National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health. J Am Coll Cardiol. 2006; 47: 485–491.
4. Widimsky P, Groch L, Zelizko M, Aschermann M, Bednar F, Suryapranata H. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory: the PRAGUE study. Eur Heart J. 2000; 21: 823–831.
5. Widimsky P, Budesinsky T, Vorac D, Groch L, Zelizko M, Aschermann M, Branny M, Stasek J, Formanek P; PRAGUE Study Group Investigators. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction: final results of the randomized national multicentre trial: PRAGUE-2. Eur Heart J. 2003; 24: 94–104.
6. Andersen HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek H, Thayssen P, Abildgaard U, Pedersen F, Madsen JK, Grande P, Villadsen AB, Krusell LR, Haghfelt T, Lomholt P, Husted SE, Vigholt E, Kjaergard HK, Mortensen LS; DANAMI-2 Investigators. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med. 2003; 349: 733–742.
7. Grines CL, Westerhausen DR Jr, Grines LL, Hanlon JT, Logemann TL, Niemela M, Weaver WD, Graham M, Boura J, ONeill WW, Balestrini C; Air PAMI Study Group. A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: the Air Primary Angioplasty in Myocardial Infarction study. J Am Coll Cardiol. 2002; 39: 1713–1719.
8. Dalby M, Bouzamondo A, Lechat P, Montalescot G. Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis. Circulation. 2003; 108: 1809–1814.
9. Nallamothu BK, Bates ER, Herrin J, Wang Y, Bradley EH, Krumholz HM; NRMI Investigators. Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis. Circulation. 2005; 111: 761–767.
10. Henry TD, Unger BT, Sharkey SW, Lips DL, Pedersen WR, Madison JD, Mooney MR, Flygenring BP, Larson DM. Design of a standardized system for transfer of patients with ST-elevation myocardial infarction for percutaneous coronary intervention. Am Heart J. 2005; 150: 373–384.[CrossRef][Medline] [Order article via Infotrieve]
11. Moyer P, Feldman J, Levine J, Beshansky J, Selker HP, Barnewolt B, Brown DFM, Cardoza JP Jr, Grossman SA, Jacobs A, Kerman BJ, Kimmelstiel C, Larson R, Losordo D, Pearlmutter M, Pozner C, Ramirez A, Rosenfield K, Ryan TJ, Zane RD, Cannon CP. Implications of the mechanical (PCI) vs thrombolytic controversy for ST segment elevation myocardial infarction on the organization of emergency medical services: the Boston EMS experience. Crit Path Cardiol. 2004; 3: 53–61.
12. Advisory Committee on Outcome Assessment in Cardiovascular Care. Final report on interventional cardiology. Baltimore, Md: Maryland Health Care Commission; June 2003. Available at: http://mhcc.maryland.gov/. Accessed March 30, 2007.
13. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, Jacobs AK, Kern MJ, King SB III, Morrison DA, ONeill WW, Schaff HV, Whitlow PL, Williams DO, Antman EM, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation. 2006; 113: 156–175.
This article has been cited by other articles:
![]() |
F. V. Aguirre, J. J. Varghese, M. P. Kelley, W. Lam, C. L. Lucore, J. B. Gill, L. Page, L. Turner, C. Davis, and F. L. Mikell Rural Interhospital Transfer of ST-Elevation Myocardial Infarction Patients for Percutaneous Coronary Revascularization: The Stat Heart Program Circulation, March 4, 2008; 117(9): 1145 - 1152. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |